Megalencephalic leukoencephalopathy with subcortical cysts: an update and extended mutation analysis of MLC1

P K Ilja Boor1, Koen de Groot, Vlatka Mejaski-Bosnjak

  • 1Department of Pediatrics/Child Neurology, VU University Medical Center, Amsterdam, The Netherlands. ilja.boor@vumc.nl

Human Mutation
|May 3, 2006
PubMed

Insights

Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare genetic disorder. Extended mutation analysis of the MLC1 gene helps identify more mutations in patients, improving diagnosis.

Area of Science:

  • Genetics
  • Neurology
  • Biochemistry

Background:

  • Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is an autosomal recessive pediatric cerebral white matter disorder.
  • Histopathology reveals myelin splitting and intramyelinic vacuole formation.
  • MLC is primarily caused by mutations in the MLC1 gene, encoding the MLC1 protein.

Purpose of the Study:

  • To report 13 novel mutations in the MLC1 gene.
  • To evaluate the utility of extended mutation analysis in identifying mutations missed by standard methods.
  • To improve diagnostic yield in MLC patients.

Main Methods:

  • Standard mutation analysis of the MLC1 gene.
  • Extended mutation analysis, including promoter, UTRs, and intronic regions.
  • Analysis of 13 novel mutations in MLC patients.

Main Results:

  • Fifty mutations in the MLC1 gene have been identified to date.
  • Standard analysis fails to detect mutations in approximately 20% of typical MLC cases.
  • Extended mutation analysis successfully identified previously undetected mutations, highlighting its value.

Conclusions:

  • Extended mutation analysis is crucial for identifying missed mutations in the MLC1 gene.
  • This approach can increase diagnostic yield in patients with suspected MLC.
  • Further investigation may be needed to identify additional genes involved in MLC.